HRP970474B1 - Compounds for and a method of inhibiting matrix metalloproteinases - Google Patents
Compounds for and a method of inhibiting matrix metalloproteinasesInfo
- Publication number
- HRP970474B1 HRP970474B1 HR970474A HRP970474A HRP970474B1 HR P970474 B1 HRP970474 B1 HR P970474B1 HR 970474 A HR970474 A HR 970474A HR P970474 A HRP970474 A HR P970474A HR P970474 B1 HRP970474 B1 HR P970474B1
- Authority
- HR
- Croatia
- Prior art keywords
- compounds
- matrix metalloproteinases
- inhibiting matrix
- inhibiting
- metalloproteinases
- Prior art date
Links
- 102000002274 Matrix Metalloproteinases Human genes 0.000 title 1
- 108010000684 Matrix Metalloproteinases Proteins 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/91—Dibenzofurans; Hydrogenated dibenzofurans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
- C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/76—Dibenzothiophenes
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Lubricants (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2506396P | 1996-09-04 | 1996-09-04 | |
| US5571497P | 1997-08-07 | 1997-08-07 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HRP970474A2 HRP970474A2 (en) | 1998-12-31 |
| HRP970474B1 true HRP970474B1 (en) | 2002-10-31 |
Family
ID=26699217
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR970474A HRP970474B1 (en) | 1996-09-04 | 1997-09-04 | Compounds for and a method of inhibiting matrix metalloproteinases |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6294674B1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP0929542A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2002514180A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20000068415A (cg-RX-API-DMAC10.html) |
| AU (1) | AU736347B2 (cg-RX-API-DMAC10.html) |
| BR (1) | BR9712794A (cg-RX-API-DMAC10.html) |
| CA (1) | CA2256631A1 (cg-RX-API-DMAC10.html) |
| HR (1) | HRP970474B1 (cg-RX-API-DMAC10.html) |
| NZ (1) | NZ333064A (cg-RX-API-DMAC10.html) |
| WO (1) | WO1998009957A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6919375B1 (en) | 1996-01-23 | 2005-07-19 | Shionogi & Co., Ltd. | Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
| NZ325939A (en) * | 1996-01-23 | 2000-06-23 | Shionogi & Co | Sulphonated amino acid derivatives and matrix metalloproteinase inhibitors (MMP) containing these derivatives |
| MXPA99001974A (es) * | 1996-12-09 | 2002-03-27 | Warner Lambert Co | Metodo para tratar y prevenir fallas cardiacas y dilatacion ventricular. |
| OA11589A (en) | 1998-07-30 | 2004-07-30 | Warner Lambert Co | Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases. |
| US6350885B1 (en) | 1998-07-30 | 2002-02-26 | Warner-Lambert Company | Tricyclic heteroaromatics and their derivatives as inhibitors of matrix metalloproteinases |
| WO2000015213A1 (en) * | 1998-09-11 | 2000-03-23 | Shionogi & Co., Ltd. | Remedal or preventive agent for congestive heart failure |
| CN1229339C (zh) * | 2000-03-27 | 2005-11-30 | 斯克里普斯研究学院 | 抑制血管生成和肿瘤生长的化合物,含有该化合物的药用制剂,以及该化合物的制药用途 |
| GB2365425A (en) * | 2000-08-01 | 2002-02-20 | Parke Davis & Co Ltd | Alkyl amino acid derivatives useful as pharmaceutical agents |
| US7186855B2 (en) | 2001-06-11 | 2007-03-06 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| US7232924B2 (en) | 2001-06-11 | 2007-06-19 | Xenoport, Inc. | Methods for synthesis of acyloxyalkyl derivatives of GABA analogs |
| US6818787B2 (en) | 2001-06-11 | 2004-11-16 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| US8048917B2 (en) | 2005-04-06 | 2011-11-01 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| US20030129672A1 (en) * | 2001-08-29 | 2003-07-10 | Dyer Richard Dennis | Method for identifying metalloenzyme inhibitors |
| PE20030701A1 (es) | 2001-12-20 | 2003-08-21 | Schering Corp | Compuestos para el tratamiento de trastornos inflamatorios |
| WO2004060346A2 (en) | 2002-12-30 | 2004-07-22 | Angiotech International Ag | Drug delivery from rapid gelling polymer composition |
| CN1318411C (zh) * | 2005-03-21 | 2007-05-30 | 中国海洋大学 | 氢化轮枝霉酮类化合物及其制备方法和用途 |
| AU2006332694A1 (en) * | 2005-12-30 | 2007-07-12 | Alantos Pharmaceuticals, Holding, Inc. | Substituted bis-amide metalloprotease inhibitors |
| EP2074107A2 (en) * | 2006-10-27 | 2009-07-01 | Wyeth a Corporation of the State of Delaware | Tricyclic compounds as matrix metalloproteinase inhibitors |
| GB0621973D0 (en) * | 2006-11-03 | 2006-12-13 | Philogen Spa | Binding molecules and uses thereof |
| AR066412A1 (es) * | 2007-05-04 | 2009-08-19 | Wyeth Corp | Derivados de dibenzofurano y dibenzotiofeno, composiciones farmaceuticas que los contienen y usos en patologias tales como trastornos oseos, crecimiento de tumores, diabetes y obesidad. |
| CA2692004C (en) * | 2007-06-15 | 2013-04-09 | Board Of Regents, The University Of Texas System | Methods and compositions to inhibit edema factor and adenylyl cyclase |
| JP2012051804A (ja) * | 2008-12-26 | 2012-03-15 | Kyoto Univ | Eg5阻害剤 |
| TWI747873B (zh) * | 2016-02-01 | 2021-12-01 | 美商百歐克斯製藥公司 | 苯并吡唑化合物及其類似物 |
| WO2021147882A1 (zh) * | 2020-01-21 | 2021-07-29 | 深圳信立泰药业股份有限公司 | 一种二苯并呋喃类衍生物组织蛋白酶k抑制剂及其制备方法和医药用途 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2065966C3 (de) | 1969-09-06 | 1978-11-16 | Ajinomoto Co., Inc., Tokio | N-Fluorenyl-sulfonyl-aminocarbonsäuren sowie diese enthaltende Mittel |
| US3845097A (en) | 1969-09-06 | 1974-10-29 | Ajinomoto Kk | N-substituted amino acids and novel ester |
| US4097472A (en) | 1974-11-08 | 1978-06-27 | Mitsubishi Chemical Industries Limited | N2 -arylsulfonyl-l-argininamides and the pharmaceutically acceptable salts thereof |
| DE2236876C3 (de) * | 1971-08-19 | 1981-02-12 | Ajinomoto Co., Inc., Tokio | N-Substituierte Aminocarbonsäuren und diese Verbindungen enthaltende Arzneimittel |
| EP0183271B1 (en) * | 1984-11-30 | 1990-05-16 | Shosuke Okamoto | Lysin derivative and proteinase inhibitor |
| PH31294A (en) * | 1992-02-13 | 1998-07-06 | Thomae Gmbh Dr K | Benzimidazolyl derivatives, pharmaceutical compositions containing these compounds and process for preparing them. |
| US5455258A (en) | 1993-01-06 | 1995-10-03 | Ciba-Geigy Corporation | Arylsulfonamido-substituted hydroxamic acids |
| US5627206A (en) | 1995-06-02 | 1997-05-06 | Warner-Lambert Company | Tricyclic inhibitor of matrix metalloproteinases |
| US5665764A (en) | 1995-06-02 | 1997-09-09 | Warner-Lambert Company | Tricyclic inhibitors of matrix metalloproteinases |
| DK0828726T3 (da) | 1995-06-02 | 2002-01-21 | Warner Lambert Co | Tricykliske inhibitorer af matrixmetalloproteinaser |
| SK282833B6 (sk) | 1995-11-17 | 2002-12-03 | Warner-Lambert Company | Sulfónamidové inhibítory matricových metaloproteináz a farmaceutická kompozícia obsahujúca tieto inhibítory |
| NZ325939A (en) | 1996-01-23 | 2000-06-23 | Shionogi & Co | Sulphonated amino acid derivatives and matrix metalloproteinase inhibitors (MMP) containing these derivatives |
| NZ333063A (en) | 1996-09-04 | 2000-12-22 | Warner Lambert Co | Dibenzofuran sulfonamide derivatives as matrix metalloproteinase inhibitors |
-
1997
- 1997-09-02 KR KR1019997001757A patent/KR20000068415A/ko not_active Abandoned
- 1997-09-02 JP JP51281898A patent/JP2002514180A/ja not_active Abandoned
- 1997-09-02 CA CA002256631A patent/CA2256631A1/en not_active Abandoned
- 1997-09-02 EP EP97939751A patent/EP0929542A1/en not_active Withdrawn
- 1997-09-02 NZ NZ333064A patent/NZ333064A/xx unknown
- 1997-09-02 WO PCT/US1997/015444 patent/WO1998009957A1/en not_active Ceased
- 1997-09-02 AU AU41770/97A patent/AU736347B2/en not_active Ceased
- 1997-09-02 US US09/254,403 patent/US6294674B1/en not_active Expired - Fee Related
- 1997-09-02 BR BR9712794-9A patent/BR9712794A/pt not_active Application Discontinuation
- 1997-09-04 HR HR970474A patent/HRP970474B1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US6294674B1 (en) | 2001-09-25 |
| WO1998009957A1 (en) | 1998-03-12 |
| EP0929542A1 (en) | 1999-07-21 |
| KR20000068415A (ko) | 2000-11-25 |
| BR9712794A (pt) | 1999-12-14 |
| CA2256631A1 (en) | 1998-03-12 |
| JP2002514180A (ja) | 2002-05-14 |
| AU736347B2 (en) | 2001-07-26 |
| HRP970474A2 (en) | 1998-12-31 |
| NZ333064A (en) | 2000-11-24 |
| AU4177097A (en) | 1998-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL331254A1 (en) | Phosphonianic inhibitors of matrix metaloproteases | |
| IL117177A0 (en) | Benzopyran-containing compounds and method for their use | |
| AU7729694A (en) | Method for inhibiting metalloproteinase expression | |
| ZA959948B (en) | Matrix metalloprotease inhibitors | |
| GB2292188B (en) | Method of purging a hydraulic system | |
| ZA946218B (en) | New compound and a process for preparation thereof | |
| GB2309709B (en) | A method of knitting | |
| GB9317920D0 (en) | A method of treatment | |
| SG66483A1 (en) | A method for biasing designs of experiments | |
| GB2323279B (en) | A method of preservation | |
| ZA987722B (en) | Method of protecting plants | |
| GB2319772B (en) | 2-phenylazulene derivatives and a manufacturing method of these compounds | |
| ZA977920B (en) | Compounds for a method of inhibiting matrix metalloproteinases. | |
| GB2302315B (en) | A method of adapting a boardsail | |
| GB2290525B (en) | A method of forming a label construction | |
| GB9418826D0 (en) | Method of piling | |
| GB2280411B (en) | A method of embedding a sinker | |
| HU9601826D0 (en) | A method of treating neurogenic inflammation | |
| GB9520620D0 (en) | A method of synthesizing an endonuclease inhibitor and analogs thereof | |
| ZA977916B (en) | Method of inhibiting matrix metalloproteinases. | |
| PL306149A1 (en) | Method of protecting a transformer | |
| AU4601097A (en) | A method of data protection | |
| KR100188557B1 (en) | Method of disposing waste magnetic tapes | |
| GB9420095D0 (en) | A method of decontamination | |
| BG98749A (en) | Heterocycle compounds and method for their preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1OB | Publication of a patent application | ||
| AIPI | Request for the grant of a patent on the basis of a substantive examination of a patent application | ||
| B1PR | Patent granted | ||
| ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20030627 Year of fee payment: 7 |
|
| PBON | Lapse due to non-payment of renewal fee |
Effective date: 20040905 |